Project Details
Description
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus and in Cutaneous Lupus Erythematosus (Subacute Cutaneous Lupus Erythematos
| Status | Active |
|---|---|
| Effective start/end date | 8/1/22 → 8/31/26 |
Funding
- EMD SERONO RESEARCH & DEVELOPMENT INST
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.